Evidence map›Paper›PMID 26383016›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Elucidation of The Behavioral Program and Neuronal Network Encoded by Dorsal Raphe Serotonergic Neurons.

Daniel J Urban, Hu Zhu, Catherine A Marcinkiewcz, Michael Michaelides, Hidehiro Oshibuchi, Darren Rhea, Dipendra K Aryal, Martilias S Farrell, Emily Lowery-Gionta, Reid H J Olsen and 5 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daniel J UrbanDepartment of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, Chapel Hill, NC, USA.
Hu ZhuDepartment of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, Chapel Hill, NC, USA.
Catherine A MarcinkiewczBowles Center for Alcohol Studies and Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Michael MichaelidesDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Hidehiro OshibuchiDepartment of Psychiatry, University of California, San Francisco, CA, USA.
Darren RheaDepartment of Psychiatry, University of California, San Francisco, CA, USA.
Dipendra K AryalDepartments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, NC, USA.
Martilias S FarrellDepartment of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, Chapel Hill, NC, USA.
Emily Lowery-GiontaBowles Center for Alcohol Studies and Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Reid H J OlsenDepartment of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, Chapel Hill, NC, USA.
William C WetselDepartments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurobiology, Duke University Medical Center, Durham, NC, USA.
Thomas L KashBowles Center for Alcohol Studies and Department of Pharmacology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Yasmin L HurdDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Laurence H TecottDepartment of Psychiatry, University of California, San Francisco, CA, USA.
Bryan L RothDepartment of Pharmacology and National Institute of Mental Health Psychoactive Drug Screening Program, Chapel Hill, NC, USA.

Funding

Translational Research and Science Education (OUT)P60AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Marian Lee Logrip · 2003 to 2026
$45.5M
UNC MRDD Research CenterP30HD003110 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BELGER, AYSENIL · 1985 to 2012
$28.7M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRUMMEL, MATTHEW F · 2003 to 2019
$21.8M
Screening CoreU19MH082441 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CARON, MARC G., WETSEL, WILLIAM C · 2007 to 2016
$15.2M
Preclinical CoreU54HD079124 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BELGER, AYSENIL · 2013 to 2019
$8.0M
The Opioid mesolimbic system in heroin abuseR01DA015446 · NIDA · KAROLINSKA INSTITUTE · PI HURD, YASMIN L. · 2002 to 2018
$7.1M
PREDOCTORAL TRAINING IN PHARMACOLOGICAL SCIST32GM007040 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS, ROBERT A · 1985 to 2019
$6.0M
Neurodevelopmental Effects of Cannabis and its Epigenetic RegulationR01DA030359 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HURD, YASMIN L. · 2011 to 2020
$5.5M
RAT RESEARCH COMPONENTP50AA007611 · NIAAA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI LUMENG, LAWRENCE · 1987 to 2002
$5.3M
Mapping the Genes for Ethanol-Related PhenotypesR01AA011034 · NIAAA · STATE UNIVERSITY NEW YORK STONY BROOK · PI HITZEMANN, ROBERT J. · 1996 to 2014
$5.1M
TRAINING IN PHARMACOLOGY OF DRUGS OF ABUSET32DA007135 · NIDA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI DEVI, LAKSHMI A · 1985 to 2018
$4.9M
Targeting and Trafficking of 5-HT2A Serotonin ReceptorsR01MH061887 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROTH, BRYAN L. · 2000 to 2014
$4.5M
NIAAA NIH HHS AA07574NIAAA NIH HHS AA07611NIAAA NIH HHS AA11034NICHD NIH HHS P30 HD03110NICHD NIH HHS U54 HD079124NIDA NIH HHS DA007135NIDA NIH HHS DA015446NIDA NIH HHS DA030359NIDDK NIH HHS P30 DK063720NIGMS NIH HHS T32 GM007040NIMH NIH HHS R01 MH061887NIMH NIH HHS R01MH61887NIMH NIH HHS R21 MH079145NIMH NIH HHS U01 MH105892NIMH NIH HHS U01MH105892NIMH NIH HHS U19 MH082441NIMH NIH HHS U19MH82441
6 · The paper itself

Abstract

Elucidating how the brain's serotonergic network mediates diverse behavioral actions over both relatively short (minutes-hours) and long period of time (days-weeks) remains a major challenge for neuroscience. Our relative ignorance is largely due to the lack of technologies with robustness, reversibility, and spatio-temporal control. Recently, we have demonstrated that our chemogenetic approach (eg, Designer Receptors Exclusively Activated by Designer Drugs (DREADDs)) provides a reliable and robust tool for controlling genetically defined neural populations. Here we show how short- and long-term activation of dorsal raphe nucleus (DRN) serotonergic neurons induces robust behavioral responses. We found that both short- and long-term activation of DRN serotonergic neurons induce antidepressant-like behavioral responses. However, only short-term activation induces anxiogenic-like behaviors. In parallel, these behavioral phenotypes were associated with a metabolic map of whole brain network activity via a recently developed non-invasive imaging technology DREAMM (DREADD Associated Metabolic Mapping). Our findings reveal a previously unappreciated brain network elicited by selective activation of DRN serotonin neurons and illuminate potential therapeutic and adverse effects of drugs targeting DRN neurons.

Indexed as

AnimalsAnxietyBehavior, AnimalBrainCircadian RhythmDepressionDesigner DrugsDorsal Raphe NucleusMaleMiceMice, TransgenicSerotonergic NeuronsTime FactorsDesigner Drugs

Identifiers

PMID26383016
PMCPMC4793125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.